🇺🇸 FDA
Pipeline program

Columvi 10 mg concentrate for solution for infusion, Gazyvaro 1,000 mg concentrate for solution for infusion., Maplirpacept

C4971006

Phase 2 small_molecule active

Quick answer

Columvi 10 mg concentrate for solution for infusion, Gazyvaro 1,000 mg concentrate for solution for infusion., Maplirpacept for Relapsed/Refractory Diffuse Large B Cell Lymphoma is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Relapsed/Refractory Diffuse Large B Cell Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials